DIANT® Pharma Inc. (Manchester, CT USA) was founded in 2019 and has developed continuous processing technology for nanoparticles. DIANT is dedicated to bringing advanced, continuous manufacturing technology to the market and to providing R&D services. Their proprietary, continuous manufacturing system for nanoparticles has a wide array of applications within the pharmaceutical space.


DIANT is an equipment company with a continuous manufacturing technology for Lipid Nanoparticles (“LNP”) and nanoparticle drug product development. DIANT’s equipment is a single-jet, scalable technology with end-to-end manufacturing capabilities of various types of nanoparticles, including liposomes, LNP, Polymeric Micelles, Emulsions, Suspensions, and others.

Visit Site